: Www.nutrition21.comis a leading developer of nutritional products for cardiovascular health and diabetes;
September 14, 2005 (Press Release) --
ATHENS, GREECE, September 13, 2005 -- Www.nutrition21.com(NASDAQ: NXXI) — A sub-set analysis from a Diachrome XLHealth clinical trial demonstrates that adding daily supplementation with Diachrome to prescription treatment regimens can significantly improve glycemic control in poorly controlled blood sugar levels in people with type 2 diabetes. The results of this study conducted in collaboration with XLHealth, a U.S. based and U.S. nationally recognized disease management firm handling chronically ill patients for the Centers for Medicare and Medicaid Services (CMS), were presented today at the 41st Annual Meeting of the European Association for the Study of Diabetes in Athens, Greece.
The randomized, double-blind, placebo-controlled, multi-center 12-week study was designed to examine the efficacy of Diachrome as an adjunct to medications in 369 patients with type 2 diabetes. This analysis of the trial looked specifically at 60 patients who had HbA1c ≥ 10% and were taking one or more oral antidiabetic medication, including: sulfonylureas, biguanides, and thiazolidinediones. Study participants taking Diachrome with one or more antidiabetic medication saw an average range of 0.7 – 1.9% point reduction in HbA1c levels. The study also showed that insulin resistance was significantly reduced (P
The randomized, double-blind, placebo-controlled, multi-center 12-week study was designed to examine the efficacy of Diachrome as an adjunct to medications in 369 patients with type 2 diabetes. This analysis of the trial looked specifically at 60 patients who had HbA1c ≥ 10% and were taking one or more oral antidiabetic medication, including: sulfonylureas, biguanides, and thiazolidinediones. Study participants taking Diachrome with one or more antidiabetic medication saw an average range of 0.7 – 1.9% point reduction in HbA1c levels. The study also showed that insulin resistance was significantly reduced (P
Email
Print
SPAM
